Corticosteroid injections in polymyalgia rheumatica: A double blind, prospective, randomized, placebo controlled study

Journal of Rheumatology

Volumn 27, Issue 6, 2000, Pages 1470-1476

  Salvarani, Carlo ^a   Cantini, Fabrizio ^b   Olivieri, Ignazio ^c   Barozzi, Libero ^d   Macchioni, Luigip ^a   Boiardi, Luigi ^a   Niccoli, Laura ^b   Padula, Angela ^c   Pulsatelli, Lia ^e   Meliconi, Riccardo ^e  

^a Servizio di Reumatologia   (Italy)

^b MISERICORDIA E DOLCE HOSPITAL   (Italy)

^c SAN CARLO HOSPITAL   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Acute phase reactants; Corticosteroid injections; Magnetic resonance imaging; Polymyalgia rheumatica

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; METHYLPREDNISOLONE ACETATE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHEUMATIC POLYMYALGIA;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; BURSITIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHYLPREDNISOLONE; PLACEBOS; POLYMYALGIA RHEUMATICA; PROSPECTIVE STUDIES; SHOULDER JOINT; SYNOVITIS; TENDINOPATHY; TREATMENT OUTCOME;

EID: 18544391629     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Saharani C, Macchioni PL, Boiardi L. Polymyalgia rheumatica. Lancet 1947;350:43-7.
2. Gabriel SE, Sunku J, Salvarani C, O'Fallon MW, Hunder GG. Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum 1997;40:1873-8.
3. Salvarani C, Cantini F, Olivieri I, et al. Proximal bursitis in active polymyalgia rheumatica. Ann Intern Med 1997;127:27-31.
4. Meliconi R, Pulsatelli L, Uguccioni M, et al. Leucocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment. Arthritis Rheum 1996;39:1199-207.
5. Cantini F, Salvarani C, Olivieri I, Niccoli L, Padula A, Bozza A. Hip bursitis in active polymyalgia rheumatica: report of a case. Clin Exp Rheumatol 1999;17:512-3..
6. Healey LA. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum 1984;13:322-8.
7. Canoso JJ. Aspiration and injection of joints and periarticular tissues. In: Klippel JH, Dieppe PA, editors. Rheumatology. 2nd ed. London: Mosby; 1998:2:12.1-12.12.
8. Kyle V, Hazleman BL. Stopping steroids in polymyalgia rheumatica and giant cell arteritis. BMJ 1990;300:344-5.
9. Ayouh WT, Franklin CM, Torretti D. Polymyalgia rheumatica: duration of therapy and long-term outcome. Am J Med 1985;79:309-15.
10. Salvarani C, Macchioni L, Tartoni PL, et al. Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol 1987;5:205-15.
11. Andersson R, Malmvall B-E, Bengtsson B-A. Long-term corticosteroid treatment in giant cell arteritis. Acta Med Scand 1986;220:465-9.
12. Silva M, Hazleman BL. Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double blind study. Ann Rheum Dis 1986;45:136-8.
13. Ferraccioli GF, Salaffi F, De Vita S, Casatta L, Bartoli E. Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. J Rheumatol 1996;23:624-8.
14. Feinberg HL, Sherman JD, Schrepferman CG, Dietzen CJ, Feinberg GD. The use of methotrexate in polymyalgia rheumatica. J Rheumatol 1996;23:1550-2.
15. De Vita S, Tavoni A, Jeracitano G, Gemignani G, Dolcher MP, Bombardieri S. Treatment of giant cell arteritis with cyclophosphamide pulses [letter]. J Intern Med 1992;232:373-5.
16. Dasgupta B, Dolan AL, Panayi GS, Fernandes L. An initially double-blind controlled 96 week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica. Br J Rheumatol 1998;37:189-95.
17. Owen DS Jr. Aspiration and injection of joints and soft tissues. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, editors. Textbook of rheumatology. 5th ed. Philadelphia: WB Saunders; 1997:591-608.
18. Sheeran TP, Roobottom CA, Wanklyn PD, Winkles J, Richardson K, Emery P. The effect of bed rest and intra-articular steroids on the acute phase response in rheumatoid arthritis. Clin Exp Rheumatol 1993;11:49-52.
19. Taylor HG, Fowler PD, David MJ, Dawes PT. Intra-articular steroids: confounder of clinical trials. Clin Rheumatol 1991; 10:38-42.
20. Roche NE, Fulbright JW, Wagner AD, Hunder GG, Goronzy JJ, Weyand CM. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 1993;36:1286-94.
21. Wagner AD, Goronzy JJ, Weyand CM. Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis: evidence for two components of the disease. J Clin Invest 1994;94:1134-40.
22. Steer JH, Ma DTS, Dusci L, Garas G, Pedersen KE, Joyce DA. Altered leukocyte trafficking and suppressed tumour necrosis factor-α release from peripheral blood monocytes after intraarticular glucocorticoid treatment. Ann Rheum Dis 1998;57:732-7.